Global healthcare company Sanofi and therapeutic companion software company Voluntis have agreed to a collaboration to help improve decision-making and self-management for type 2 diabetics treated with basal insulin. The
Global healthcare company Sanofi and therapeutic companion software company Voluntis have agreed to a collaboration to help improve decision-making and self-management for type 2 diabetics treated with basal insulin. The